Identification of a HLA-A0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 (vol 6, 2017)

被引：0
|
作者：
Tosi, Anna
Santa, Silvia Dalla
Cappuzzello, Elisa
Marotta, Carolina
Walerych, Dawid
Del Sal, Giannino
Zanovello, Paola
Sommaggio, Roberta
Rosato, Antonio
机构：
来源：
ONCOIMMUNOLOGY | 2018年 / 7卷 / 01期
关键词：
D O I：
10.1080/2162402X.2017.1412885
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor α2 chain
    Okano, F
    Storkus, WJ
    Chambers, WH
    Pollack, IF
    Okada, H
    CLINICAL CANCER RESEARCH, 2002, 8 (09) : 2851 - 2855
  • [42] Identification of a novel HLA-A* 0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor α2 chain (vol 8, pg 2851, 2002)
    Okano, F
    Storkus, WJ
    Chambers, WH
    Pollack, IF
    Okada, H
    CLINICAL CANCER RESEARCH, 2006, 12 (11) : 3552 - 3552
  • [43] A Novel HLA-A2-restricted CTL Epitope of Tumor-associated Antigen L6 can Inhibit Tumor Growth In Vivo
    Tu, Shih-Hsin
    Huang, Hsing-I
    Lin, Su-I
    Liu, Hsin-Yu
    Sher, Yuh-Pyng
    Chiang, Sheng-Kuo
    Chong, Pele
    Roffler, Steve
    Tseng, Guan-Chin
    Chen, Hsin-Wei
    Liu, Shih-Jen
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (03) : 235 - 244
  • [44] Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4
    Marc Lopez
    Abderrezak Ghidouche
    Caroline Rochas
    Danièle Godelaine
    Javier Carrasco
    Didier Colau
    Gérald Hames
    Félix A. Montero-Julian
    Pierre G. Coulie
    Daniel Olive
    Cancer Immunology, Immunotherapy, 2016, 65 : 1177 - 1188
  • [45] Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4
    Lopez, Marc
    Ghidouche, Abderrezak
    Rochas, Caroline
    Godelaine, Daniele
    Carrasco, Javier
    Colau, Didier
    Hames, Gerald
    Montero-Julian, Felix A.
    Coulie, Pierre G.
    Olive, Daniel
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (10) : 1177 - 1188
  • [46] Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma
    Kang, Yoon Joong
    Zeng, Wanyong
    Song, Weihua
    Reinhold, Bruce
    Choi, Jaewon
    Brusic, Vladimir
    Yamashita, Takuto
    Munshi, Aditya
    Li, Cheng
    Minvielle, Stephane
    Anderson, Kenneth C.
    Munshi, Nikhil
    Reinherz, Ellis L.
    Sasada, Tetsuro
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (03) : 343 - 351
  • [47] Identification of HLA-A0201 restricted epitope of cancer/testis antigen (CTA) Hormad1 and generation of antigen-specific T-cell receptor-engineered T cells (TCR-T) for treatment of solid tumor malignancies.
    Pan, Ke
    Chiu, Yulun
    Hasan, Farah
    Miroballi, Natalia
    Whitehurst, Angelique
    Yee, Cassian
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 65 - 66
  • [48] Identification of an HLA-A*0201-restricted T cell epitope derived from the prostate cancer-associated protein trp-p8
    Fuessel, S
    Kiessling, A
    Schmitz, M
    Stevanovic, S
    Richter, K
    Meye, A
    Weigle, B
    Rieber, EP
    Wirth, MP
    JOURNAL OF UROLOGY, 2004, 171 (04): : 110 - 111
  • [49] Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer
    Abate-Daga, Daniel
    Speiser, Daniel E.
    Chinnasamy, Nachimuthu
    Zheng, Zhili
    Xu, Hui
    Feldman, Steven A.
    Rosenberg, Steven A.
    Morgan, Richard A.
    PLOS ONE, 2014, 9 (03):
  • [50] Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K
    Lee, Ji Hee
    Park, Myong-Suk
    Hwang, Jun-Eul
    Cho, Sang-Hee
    Bae, Woo-Kyun
    Shim, Hyun-Jeong
    Kim, Dae-Eun
    Chung, Ik-Joo
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (03) : 275 - 282
12345